
Mathematician Solves Algebra's Oldest Problem
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources.
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
A mathematician has uncovered a way of answering some of algebra's oldest problems.
University of New South Wales Honorary Professor Norman Wildberger, has revealed a potentially game-changing approach to solving higher polynomial equations.
Polynomial equations involve a variable being raised to powers, such as the degree two polynomial: 1+ 4x - 3x2 = 0. Until now, a method for solving "higher order" polynomial equations, where x is raised to the power of five or higher, had proven elusive.
Wildberger has developed a fresh approach to the problem though using novel number sequences. His method was detailed in an article published in The American Mathematical Monthly co-authored with computer scientist Dr. Dean Rubine.
Wildberger's findings could have significant implications. Higher order polynomial equations play a fundamental role in both math and science, assisting in everything from writing computer programs to describing the movement of planets.
"Our solution reopens a previously closed book in mathematics history," Wildberger said in a statement.
A Brief History of Polynomials
Solutions to degree-two polynomials have been around since as far back as 1800 BC, when the Babylonians pioneered their "method of completing the square", which would evolve into the quadratic formula that became familiar to many high school math students.
Then in the 16th century, the approach of using roots of numbers dubbed "radicals" was extended to solve three- and four-degree polynomials.
In 1832, French mathematician Évariste Galois demonstrated how the mathematical symmetry behind the methods used to resolve lower-order polynomials became impossible for degree five and higher polynomials. He concluded that no general formula could solve them.
Though some approximate solutions for higher-degree polynomials have been developed in the years since, Wildberger contends that these don't belong to pure algebra.
Wildberger's 'Radical' Approach
He points to the issue of the classical formula's use of third or fourth roots, which are "radicals." These "radicals" tend to represent irrational numbers, decimals that extend to infinity without repeating and can't be written as simple fractions.
Wildberger said this makes it impossible to calculate the real answer as "you would need an infinite amount of work and a hard drive larger than the universe."
For example, the answer to the cubed root of seven, 3√7 = 1.9129118... extends forever. So although 3√7 "exists" in this formula, this infinite, never-ending decimal is being mischaracterized as a complete object.
Wildberger "doesn't believe in irrational numbers" as they rely on an imprecise concept of infinity and lead to logical problems in mathematics.
This rejection of radicals inspired Wildberger's best-known contributions to mathematics, rational trigonometry and universal hyperbolic geometry. These approaches rely on mathematical functions like squaring, adding, or multiplying, rather than irrational numbers, radicals, or functions like sine and cosine.
Wildberger's new approach to solving polynomials avoids radicals and irrational numbers, relying on special extensions of polynomials called "power series," which can have an infinite number of terms with the powers of x.
Wildberger found that by truncating the power series they were able to extract approximate numerical answers to check that the method worked.
He said: "One of the equations we tested was a famous cubic equation used by Wallis in the 17th century to demonstrate Newton's method. Our solution worked beautifully."
University of New South Wales Honorary Professor Norman Wildberger
University of New South Wales Honorary Professor Norman Wildberger
University of New South Wales
Wildberger's Mathematical Logic
Wildberger uses novel sequences of numbers that represent complex geometric relationships in his approach. These sequences belong to combinatorics, a facet of mathematics dealing with number patterns in sets of elements.
The Catalan numbers are the most famous combinatorics sequence, used to describe the number of ways you can dissect a polygon into triangles. The Catalan numbers have a number of important applications in practical life, whether it be computer algorithms, game theory or structure designs.
The Catalan numbers also play a role in biology, helping count the possible folding patterns of RNA molecules.
Wildberger said: "The Catalan numbers are understood to be intimately connected with the quadratic equation. Our innovation lies in the idea that if we want to solve higher equations, we should look for higher analogues of the Catalan numbers."
This approach sees the Catalan numbers enhanced from a one-dimensional to multi-dimensional array based on the number of ways a polygon can be divided using non-intersecting lines.
"We've found these extensions, and shown how, logically, they lead to a general solution to polynomial equations," Wildberger said. "This is a dramatic revision of a basic chapter in algebra."
Degree five polynomials, or quintics, also have a solution under Wildberger's approach.
Practical Applications of Wildberger's Method
Theoretical mathematics aside, Wildberger believes this new method could have significant promise when it comes to creating computer programs capable of solving equations using the algebraic series rather than radicals.
"This is a core computation for much of applied mathematics, so this is an opportunity for improving algorithms across a wide range of areas," he said.
The novel array of numbers, dubbed the "Geode" by Wildberger and co-author Rubine, offers significant potential for further research.
"We introduce this fundamentally new array of numbers, the Geode, which extends the classical Catalan numbers and seem to underlie them," Wildberger said.
"We expect that the study of this new Geode array will raise many new questions and keep combinatorialists busy for years. Really, there are so many other possibilities. This is only the start."
Newsweek has reached out to the University of New South Wales for comment.
Do you have a tip on a science story that Newsweek should be covering? Do you have a question about algebra? Let us know via science@newsweek.com.
Reference
Wildberger, N. J., & and Rubine, D. (2025). A Hyper-Catalan Series Solution to Polynomial Equations, and the Geode. The American Mathematical Monthly. https://doi.org/10.1080/00029890.2025.2460966
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Newsweek
9 minutes ago
- Newsweek
'Star Trek: Strange New Worlds" Canceled
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Entertainment gossip and news from Newsweek's network of contributors "Star Trek: Strange New Worlds" will reach the end of its interstellar journey with a shortened fifth season. According to The Hollywood Reporter, Paramount+ announced that "Strange New Worlds" has been renewed for a fifth season, but that Season 5 will be its last. The season will also be shorter than previous seasons, consisting only of six episodes. Read More: 'Harry Potter' Reboot Series Casts Four of Its Best Villains The good news for "Star Trek" fans is that there's still three seasons left to the series. Season 3 doesn't premiere until July 17 and Season 4 is currently in production. Anson Mount in "Star Trek: Strange New Worlds". Anson Mount in "Star Trek: Strange New Worlds". Paramount This development comes as Paramount Global announces a number of cost cutting measures, including reducing its US-based workforce by 15 percent. Executive producers Akiva Goldsman, Henry Alonso Myers and Alex Kurtzman released a joint statement, saying, "From the very beginning, 'Strange New Worlds' set out to honor what 'Star Trek' has always stood for — boundless curiosity, hope and the belief that a better future is possible." "We're deeply grateful to Paramount+ for the chance to complete our five-season mission, just as we envisioned it, alongside our extraordinary cast and crew. And to the passionate fans who've boldly joined us on this journey — THANK YOU. With three more spectacular seasons ahead for you to see and enjoy, this adventure is far from over." This news makes "Strange New Worlds" the third of recent "Star Trek" series to be cut off at the fifth season. Both "Star Trek: Discovery" and the animated comedy series "Star Trek: Lower Decks" were likewise ended at the Season 5 mark. The intention of the producers was to bring "Strange New Worlds" into the era of "Star Trek: The Original Series" and it remains to be seen whether or not the remaining three seasons will succeed in doing so. The end of "Strange New Worlds" thankfully doesn't mean the end of "Star Trek". Still to come is "Star Trek: Starfleet Academy," following a brand new group of Starfleet recruits as they learn what it means to be Starfleet officers. The series is expected to premiere sometime either later this year or in early 2026. There's also Tawny Newsome's so far untitled "Star Trek" workplace comedy still in development. In the meantime, there are still three seasons of "Star Trek: Strange New Worlds" on the way, starting with Season 3, which debuts Thursday, July 17. More TV: 'Mass Effect' Series Moving Forward With 'Star Trek' Writer Everything We Know About Netflix's Season 4 of 'Ginny & Georgia'


Newsweek
an hour ago
- Newsweek
Avocado's New Health Benefit Revealed
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. In news that may have many a millennial lunging for a slice of toast, eating an avocado a day has been linked to better sleep and boosted heart health as a result. Analysis of the largest randomized controlled trial on avocado consumption to date found a link between eating the fruit daily and improved sleep duration, despite the study being designed really to explore the superfood's impact on general health. The study had been supported by the Avocado Nutrition Center and marks the first time avocado intake has been associated with better sleep. "Sleep is emerging as a key lifestyle factor in heart health, and this study invites us to consider how nutrition—and foods like avocado—can play a role in improving it," said paper author and nutritional sciences professor Kristina Petersen of Penn State University in a statement. "Cardiovascular health is influenced by many factors, and while no single food is a silver bullet, some—like avocados—offer a range of nutrients that support multiple aspects of heart health." A stock image of a plate containing avocado on brown bread. A stock image of a plate containing avocado on brown bread. Getty Images Lisa Moskovitz, a registered dietitian and CEO at The NY Nutrition Group, spoke with Newsweek about the findings, giving avocados her seal of approval too. "Avocados are a superfood offering an assortment of heart-healthy nutrients—from cholesterol-lowering monounsaturated fats and fiber to blood pressure-regulating potassium and magnesium," she said. "There is a lot going on in a relatively small package. "I always recommend this Mediterranean staple to my clients as part of a wholesome, healthy and disease-fighting balanced diet." The study involved 969 racially and ethnically diverse American adults, all with elevated waist circumferences—a cardiovascular risk factor that affects nearly 60 percent of U.S. adults. Participants were randomized into two groups: one group consumed one avocado per day while the other had fewer than two avocados per month. Both groups otherwise maintained their usual diets over a six-month period. Although sleep was not the intended focus of the trial, the team's analysis revealed that those in the daily avocado group self-reported longer sleep durations. This finding adds to the growing scientific consensus around the fruit's health-promoting potential. Crucially, it also connects avocado intake to one of the American Heart Association's Life's Essential 8™—a set of key health behaviors and clinical measures that promote optimal cardiovascular health. Alongside sleep, the Essential 8 includes diet quality, physical activity, nicotine exposure, body weight, blood pressure, blood lipids and blood glucose. While the study showed modest reductions in LDL cholesterol and total cholesterol levels, and an increase in overall diet quality measured by the Healthy Eating Index 2015, there were no significant effects on the other Essential 8 components. However, the researchers note that this avenue—avocados and sleep—is ripe for future exploration. Why Do Avocados Improve Sleep? Avocados contain several nutrients that may play a role in sleep regulation. One-third of a medium avocado delivers 13 milligrams of tryptophan, an amino acid precursor to melatonin, the hormone that helps regulate sleep-wake cycles. It also contains 45 micrograms of folate, essential for melatonin production, and 15 milligrams of magnesium, which contributes to muscle relaxation and, as a result, improves sleep quality. Then there is the fruit's signature nutrient profile: 3 grams of fiber—one-third of which is soluble fiber known to reduce cholesterol—and 5 grams of heart-healthy monounsaturated fats, which help lower LDL cholesterol levels and reduce the risk of stroke and heart disease. Do you have a tip on a science story that Newsweek should be covering? Do you have a question about heart health? Let us know via science@ Reference Damani, J. J., Kris‐Etherton, P. M., Lichtenstein, A. H., Matthan, N. R., Sabaté, J., Li, Z., Reboussin, D., & Petersen, K. S. (2025). Effect of Daily Avocado Intake on Cardiovascular Health Assessed by Life's Essential 8: An Ancillary Study of HAT, a Randomized Controlled Trial. Journal of the American Heart Association, 14(5).
Yahoo
2 hours ago
- Yahoo
Sofinnova taps NVIDIA to bolster portfolio companies' computational power
Sofinnova Partners has partnered with NVIDIA in a move intended to equip its life sciences portfolio companies with faster processing speeds for processing complex biological datasets. The French VC said that amid increasing demand for computational resources driven by artificial intelligence (AI), its portfolio companies will now be able to access NVIDIA Blackwell and related graphical processing units (GPU) offered by the technology giant via NVIDIA DGX Cloud Lepton, an AI platform and marketplace that connects developers to global AI infrastructure. According to a report by GlobalData, the global revenue for AI platforms across healthcare is forecast to reach $18.8bn by 2027. Sofinnova's most recent fund is focused on digital medicine. By partnering with Nvidia, its portfolio companies in the area, including startups BioCorteX, Bioptimus, and Cure51, will be to process biological datasets and run computational models to complete tasks 'within days' that would previously have taken months through Cloud Lepton, the VC said. Sofinnova Partners' chairman and managing partner Antoine Papiernik commented: "This collaboration supercharges computation for life sciences innovation. The convergence of biology, AI, computation, and data isn't just our investment thesis – it's the defining battleground of the next decade. 'By securing access to Nvidia's infrastructure, we're not just funding companies; we're empowering them with the computational backbone needed to outperform incumbents and redefine what's possible in drug discovery, precision medicine, and scalable solutions that address both human health and sustainability." In March, Sofinnova's life sciences fund reached €4bn ($4.6bn). Papiernik said that following the milestone, the VC plans to invest in 50 to 60 new companies, adding to the more than 100 life sciences companies it has invested in to date, including the cardiovascular medtech company Shockwave Medical. Sofinnova also has Sofinnova AI. Launched in 2023 and combining data analytics and machine learning, the VC has stated that this fund is intended to strengthen its ability to identify innovations and accelerate the development of life sciences companies. News of the partnership coincides with Nvidia's GTC conference, taking place in Paris, France from 10-12 June. During a presentation at the event, Nvidia CEO Jensen Huang said: 'Europe isn't just adopting AI — it's building it.' Notable healthcare announcements at the event included a new collaboration between Nvidia and Novo Nordisk to accelerate drug discovery efforts through AI use cases, with Nvidia's aim to create customised AI models and agents that Novo Nordisk can use ind early research and clinical development. Nvidia also announced a new partnership with GE HealthCare intended to advance innovation in autonomous imaging with a focus on developing autonomous X-ray technologies and ultrasound applications. "Sofinnova taps NVIDIA to bolster portfolio companies' computational power" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data